You have 9 free searches left this month | for more free features.

Ezetimibe

Showing 1 - 25 of 429

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hyperlipidemias Trial in Qingdao (ezetimibe tablet, ezetimibe tablet(Ezetrol ®))

Completed
  • Hyperlipidemias
  • ezetimibe tablet
  • ezetimibe tablet(Ezetrol ®)
  • Qingdao, Shandong, China
    Clinical Research Center
Dec 27, 2022

Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)

Not yet recruiting
  • Healthy Volunteer Study
  • Fixed-Dose Combination (FDC) Tablet
  • (no location specified)
Sep 22, 2023

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

Healthy Lactating Women Trial in Las Vegas (Bempedoic Acid 180 MG Oral Tablet, Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral

Recruiting
  • Healthy Lactating Women
  • Bempedoic Acid 180 MG Oral Tablet
  • Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral Tablet
  • Las Vegas, Nevada
    PPD Development, Las Vegas Research Unit
Aug 27, 2023

Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin

Not yet recruiting
  • Coronary Artery Calcification
  • +2 more
  • Guideline directed statin therapy
  • High intensity statin plus ezetimibe therapy
  • (no location specified)
Apr 25, 2023

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul

Not yet recruiting
  • Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
  • ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
  • high-intensity statin monotherapy (atoravastatin 40mg)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 21, 2023

Hypercholesterolemia Trial (Inclisiran, Ezetimibe, Matching Placebo for Inclisiran)

Not yet recruiting
  • Hypercholesterolemia
  • (no location specified)
Feb 28, 2023

Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe

Not yet recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Bempedoic acid and/or its fixed dose combination with ezetimibe
  • (no location specified)
Mar 23, 2023

Dyslipidemias, Stroke, Acute Ischemic Trial in Ansan, Seoul (combination of high-dose rosuvastatin and ezetimibe, high-dose

Recruiting
  • Dyslipidemias
  • Stroke, Acute Ischemic
  • combination of high-dose rosuvastatin and ezetimibe
  • high-dose rosuvastatin single administration
  • Ansan, Gyeonggi-do, Korea, Republic of
  • +2 more
May 22, 2023

Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • high-intensity statin arm
  • low-intensity statin plus ezetimibe
  • (no location specified)
Oct 12, 2022

Atherosclerotic Cardiovascular Disease Trial (Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg)

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Atozet 10/40 mg or 10/80 mg
  • Lipitor 40 mg or 80 mg
  • (no location specified)
Mar 8, 2023

Status of Dyslipidemia Following Administration of Statin and

Recruiting
  • Dyslipidemias
  • Statin+Ezetimibe compound
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Nov 7, 2022

Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

Recruiting
  • Coronary Artery Disease
  • Dyslipidemias
  • a high dose of statin/ezetimib
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongin Severance Hospital
Jun 14, 2023

Metabolic Syndrome Trial in Houston (Simvastatin, Vytorin, Placebo)

Completed
  • Metabolic Syndrome
  • Houston, Texas
    Baylor College of Medicine
Jul 21, 2022

Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)

Terminated
  • Chronic Hepatitis C
  • 20mg ezetimibe
  • +2 more
  • Hines, Illinois
    Edward Hines Jr. VA Hospital, Hines, IL
May 10, 2022

Efficacy of Fixed Dose Combination Therapy With Atorvastatin and

Enrolling by invitation
  • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Nov 4, 2022

    Hypercholesterolemia Trial (Atorvastatin, Ezetimibe, Ezetimibe/atorvastatin)

    Completed
    • Hypercholesterolemia
    • (no location specified)
    Feb 7, 2022

    Hypercholesterolemia Trial (Atorvastatin, Ezetimibe, Ezetimibe/atorvastatin)

    Completed
    • Hypercholesterolemia
    • (no location specified)
    Feb 7, 2022

    Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)

    Not yet recruiting
    • Dyslipidemias
    • Atherosclerotic Cardiovascular Disease
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jan 29, 2023

    Ezetimibe-Rosuvastatin Evaluation Study

    Not yet recruiting
    • Hypercholesterolemia
    • +2 more
      • Athens, Greece
        Athens University Hospital
      May 19, 2022

      Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Ezetimibe 10mg, Obicetrapib )

      Active, not recruiting
      • Dyslipidemias
      • +2 more
      • Gardena, California
      • +6 more
      Jul 14, 2022

      Primary Hypercholesterolemia Trial (Ezetimibe, Atorvastatin, Rosuvastatin)

      Completed
      • Primary Hypercholesterolemia
      • Ezetimibe
      • +2 more
      • (no location specified)
      Feb 7, 2022

      Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity Trial in Korea, Republic of (Rosuzet 10/5

      Recruiting
      • Myocardial Infarction
      • +2 more
      • Ezetimibe 10mg + Rosuvastatin 5mg
      • Rosuvastatin 20mg
      • Bucheon, Gyeonggido, Korea, Republic of
      • +6 more
      Sep 2, 2022

      Vytorin Tablet Among Filipino Patients

      Completed
      • Hypercholesterolemia
      • Vytorin (R) (Ezetimibe + Simvastatin)
      • (no location specified)
      Feb 7, 2022

      Cholesterol Trial (ezetimibe, Comparator: Placebo (unspecified), simvastatin)

      Completed
      • Cholesterol
      • ezetimibe
      • +2 more
      • (no location specified)
      Feb 7, 2022